journal article·2024-09

Infectious and Inflammatory Microenvironment Self‐Adaptive Artificial Peroxisomes with Synergetic Co‐Ru Pair Centers for Programmed Diabetic Ulcer Therapy

Yang Gao, Yuting Deng, Wei Geng, Sutong Xiao, Ting Wang, Xiaohui Xu, Mohsen Adeli, Liang Cheng, Li Qiu, Chong Cheng

Advanced Materials· Volume 36· Issue 38
Publisher page

Abstract

Abstract Complex microenvironments with bacterial infection, persistent inflammation, and impaired angiogenesis are the major challenges in chronic refractory diabetic ulcers. To address this challenge, a comprehensive strategy with highly effective and integrated antimicrobial, anti‐inflammatory, and accelerated angiogenesis will offer a new pathway to the rapid healing of infected diabetic ulcers. Here, inspired by the tunable reactive oxygen species (ROS) regulation properties of natural peroxisomes, this work reports the design of infectious and inflammatory microenvironments self‐adaptive artificial peroxisomes with synergetic Co‐Ru pair centers (APCR) for programmed diabetic ulcer therapy. Benefiting from the synergistic Co and Ru atoms, the APCR can simultaneously achieve ROS production and metabolic inhibition for bacterial sterilization in the infectious microenvironment. After disinfection, the APCR can also eliminate ROS to alleviate oxidative stress in the inflammatory microenvironment and promote wound regeneration. The data demonstrate that the APCR combines highly effective antibacterial, anti‐inflammatory, and provascular regeneration capabilities, making it an efficient and safe nanomedicine for treating infectious and inflammatory diabetic foot ulcers via a programmed microenvironment self‐adaptive treatment pathway. This work expects that synthesizing artificial peroxisomes with microenvironments self‐adaptive and bifunctional enzyme‐like ROS regulation properties will provide a promising path to construct ROS catalytic materials for treating complex diabetic ulcers, trauma, or other infection‐caused diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Diabetic Foot Ulcer Assessment and Management · Immune cells in cancer · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ultrasound Frontiers Science Center for Disease‐related Molecular Network National Clinical Research Center for Geriatrics Med‐X Center for Materials West China Hospital Sichuan University Chengdu 610041 China

College of Polymer Science and Engineering State Key Laboratory of Polymer Materials Engineering Sichuan University Chengdu 610065 China

Department of Organic Chemistry Lorestan University Khorramabad 6815144316 Iran

Institute of Chemistry and Biochemistry Freie Universitat Berlin Takustr. 3 14195 Berlin Germany

Department of Materials Science and Engineering The Macau University of Science and Technology Taipa Macau 999078 China

Department of Endodontics Department of Orthodontics State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu 610041 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Health Commission of Sichuan Province

References (63)

Show source-provided references
1. 10.1186/s12933-023-02107-910.1186/s12933-023-02107-9 ↗
2. 10.1056/NEJMra161543910.1056/NEJMra1615439 ↗
3. 10.1161/CIR.000000000000119210.1161/CIR.0000000000001192 ↗
4. 10.1002/smll.20220016510.1002/smll.202200165 ↗
5. 10.1002/advs.20220330810.1002/advs.202203308 ↗
6. 10.1038/s41467-022-34481-510.1038/s41467-022-34481-5 ↗
7. 10.1021/acsnano.3c0230410.1021/acsnano.3c02304 ↗
8. 10.1038/s41467-022-33920-710.1038/s41467-022-33920-7 ↗
9. 10.1038/s41467-022-30125-w10.1038/s41467-022-30125-w ↗
10. 10.1021/acsnano.2c1144810.1021/acsnano.2c11448 ↗
11. 10.2337/dc17-183610.2337/dc17-1836 ↗
12. Senneville É. · Clin. Infect. Dis. · 2024 · 40
13. 10.1002/adma.20230768010.1002/adma.202307680 ↗
14. 10.1038/s41467-021-26456-910.1038/s41467-021-26456-9 ↗
15. 10.1039/D3CS00087G10.1039/D3CS00087G ↗
16. 10.1002/smll.20220751010.1002/smll.202207510 ↗
17. 10.1016/j.actbio.2021.10.04510.1016/j.actbio.2021.10.045 ↗
18. 10.1002/advs.20200279710.1002/advs.202002797 ↗
19. 10.1002/adma.20221104110.1002/adma.202211041 ↗
20. 10.1002/adma.20200547710.1002/adma.202005477 ↗
21. 10.1002/advs.20210434110.1002/advs.202104341 ↗
22. 10.1002/adma.20221114710.1002/adma.202211147 ↗
23. 10.1021/acs.nanolett.9b0483010.1021/acs.nanolett.9b04830 ↗
24. 10.1016/j.biomaterials.2023.12218310.1016/j.biomaterials.2023.122183 ↗
25. 10.1021/acsnano.0c0961710.1021/acsnano.0c09617 ↗
26. 10.1039/D2CS00460G10.1039/D2CS00460G ↗
27. 10.1038/s41467-021-25561-z10.1038/s41467-021-25561-z ↗
28. 10.1038/s41467-022-35472-210.1038/s41467-022-35472-2 ↗
29. 10.3389/fmolb.2022.88982510.3389/fmolb.2022.889825 ↗
30. 10.1038/s41467-020-15498-010.1038/s41467-020-15498-0 ↗
31. 10.1002/adma.20170332210.1002/adma.201703322 ↗
32. 10.1002/adma.20220727510.1002/adma.202207275 ↗
33. 10.1002/anie.20181019910.1002/anie.201810199 ↗
34. 10.1002/anie.20201620710.1002/anie.202016207 ↗
35. 10.1002/adma.20211063110.1002/adma.202110631 ↗
36. 10.1002/smll.20190700110.1002/smll.201907001 ↗
37. 10.1002/admi.20200074010.1002/admi.202000740 ↗
38. 10.1002/advs.20180076310.1002/advs.201800763 ↗
39. 10.1143/JJAP.33.396210.1143/JJAP.33.3962 ↗
40. 10.1002/anie.20211366410.1002/anie.202113664 ↗
41. 10.1002/adma.20210864610.1002/adma.202108646 ↗
42. 10.1002/adfm.20230427110.1002/adfm.202304271 ↗
43. 10.1038/s41467-021-25303-110.1038/s41467-021-25303-1 ↗
44. 10.1021/ja00414a02910.1021/ja00414a029 ↗
45. 10.1093/nsr/nwab18610.1093/nsr/nwab186 ↗
46. 10.1016/j.procbio.2021.09.00910.1016/j.procbio.2021.09.009 ↗
47. 10.1002/anie.20220692610.1002/anie.202206926 ↗
48. 10.1007/s12274-022-4150-810.1007/s12274-022-4150-8 ↗
49. 10.1038/s41579-020-00486-410.1038/s41579-020-00486-4 ↗
50. 10.1016/j.carres.2003.07.00910.1016/j.carres.2003.07.009 ↗
51. 10.1016/S0021-9258(17)31622-810.1016/S0021-9258(17)31622-8 ↗
52. 10.1016/j.ijantimicag.2017.08.02410.1016/j.ijantimicag.2017.08.024 ↗
53. 10.1002/adma.20220620810.1002/adma.202206208 ↗
54. 10.1126/sciadv.abj015310.1126/sciadv.abj0153 ↗
55. 10.1039/C6IB00070C10.1039/C6IB00070C ↗
56. 10.1126/sciadv.aba431110.1126/sciadv.aba4311 ↗
57. 10.1002/adhm.20210279110.1002/adhm.202102791 ↗
58. 10.1038/ncb318010.1038/ncb3180 ↗
59. 10.1002/smll.20230507610.1002/smll.202305076 ↗
60. 10.1021/acsami.1c0988910.1021/acsami.1c09889 ↗
61. 10.1021/acsnano.0c0628710.1021/acsnano.0c06287 ↗
62. 10.1002/adma.20220052110.1002/adma.202200521 ↗
63. 10.1002/adma.20210359310.1002/adma.202103593 ↗